Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-12-30

FDA Approved: GABAPENTIN — Original Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approves Exelan Pharmaceuticals, Inc.'s original application for gabapentin as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)